1210A Phase 3, Randomized, Double-Blind, Non-inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Neutropenic Patients

1210. A Phase 3, Randomized, Double-Blind, Non-inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Neutropenic Patients Thomas Patterson,; Dominik Selleslag,; Kathleen Mullane,; Oliver Cornely,; William Hope,; Olivier Lortholary,; Bernhardt Zeiher,; Rochelle Maher,; Misun Lee,; Wenmei Huang,; Dimitrios Kontoyiannis,; The University of Texas Health Science Center, San Antonio, TX; A.Z. Sint-Jan, Brugge, Belgium; University of Chicago Medicine, Chicago, IL; Uniklinik koln, Cologne, Germany; Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom; ., Institut Pasteur, Paris, France; Astellas Pharma Global Development, Northbrook, IL; The University of Texas MD Anderson Cancer Center, Houston, TX